Get the Stockscreener App
9.04
0.88%
-0.08
After Hours:
9.04
Theravance Biopharma Inc Stock (TBPH) Latest News
(TBPH) Technical Data - Stock Traders Daily
TBPHTheravance Biopharma, Inc. Latest Stock News & Market Updates - StockTitan
Exclusive: Theravance Biopharma Takes Center Stage at Major Healthcare Conference - StockTitan
Theravance biopharma SVP Rhonda Farnum sells $36,000 in shares - MSN
Theravance Bio (TBPH) Soars 8.3%: Is Further Upside Left in the Stock? - MSN
Theravance Biopharma (NASDAQ:TBPH) Hits New 12-Month High – Should You Buy? - Defense World
Theravance Biopharma (NASDAQ:TBPH) Trading Up 8.8%Still a Buy? - MarketBeat
Theravance Biopharma (NASDAQ:TBPH) Reaches New 12-Month HighHere's Why - MarketBeat
Theravance Biopharma stock hits 52-week high at $10.47 - MSN
Theravance Biopharma, Inc. (NASDAQ:TBPH) SVP Rhonda Farnum Sells 4,000 Shares - MarketBeat
Theravance Biopharma stock hits 52-week high at $10.47 By Investing.com - Investing.com South Africa
Theravance Biopharma (NASDAQ:TBPH) shareholders are up 15% this past week, but still in the red over the last five years - Simply Wall St
Theravance biopharma SVP Rhonda Farnum sells $36,000 in shares By Investing.com - Investing.com South Africa
JPMorgan Chase & Co. Acquires 7,620 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Barclays PLC Increases Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Barclays PLC Has $529,000 Stake in Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat
How To Trade (TBPH) - Stock Traders Daily
Zacks Research Issues Optimistic Estimate for TBPH Earnings - Defense World
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Research Report 2024-2030 Featuring Allergan, Basilea Pharmaceutica, Merck, Pfizer, The Medicines Co, Theravance Biopharma - GlobeNewswire
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs - GlobeNewswire
(TBPH) On The My Stocks Page - Stock Traders Daily
Analysts Are Optimistic We'll See A Profit From Theravance Biopharma, Inc. (NASDAQ:TBPH) - Yahoo Finance
Franklin Resources Inc. Trims Stock Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Barclays PLC Has $529,000 Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Jane Street Group LLC Raises Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Sold by State Street Corp - MarketBeat
State Street Corp Decreases Stock Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 21,372 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World
Wellington Management Group LLP Sells 159,258 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - MarketBeat
When (TBPH) Moves Investors should Listen - Stock Traders Daily
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference - PR Newswire
Theravance Bio (TBPH) Up 3.7% Since Last Earnings Report: Can It Continue? - MSN
The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable - Yahoo Finance
Diabetic Gastroparesis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Theravance Biopharma, Eli Lilly and Company, Processa Pharmaceuticals, PTC Therapeutics - The Globe and Mail
Theravance Biopharma, Inc. (NASDAQ:TBPH) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
What is Zacks Research's Estimate for TBPH FY2024 Earnings? - MarketBeat
Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Acquired by BNP Paribas Financial Markets - MarketBeat
(TBPH) Trading Advice - Stock Traders Daily
Theravance Biopharma (STU:0TB) Shares Outstanding (EOP) : 49.17 Mil (As of Sep. 2024) - GuruFocus.com
105,609 Shares in Theravance Biopharma, Inc. (NASDAQ:TBPH) Bought by Algert Global LLC - MarketBeat
Trading (TBPH) With Integrated Risk Controls - Stock Traders Daily
Theravance's Q3 Loss Narrower Than Expected, Revenues Rise Y/Y - MSN
Multiple System Atrophy Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma - The Globe and Mail
Theravance Biopharma to Participate in an Upcoming Investor Conference - Citizentribune
Theravance Biopharma to Present at Evercore HealthCONx Conference | TBPH Stock News - StockTitan
Baupost's top Q3 trades include Jazz exit, new Dollar General stake - MSN
Theravance Biopharma (TBPH) Reports Q3 Loss, Tops Revenue Estimates - MSN
2.27%
5.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):